摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-Isobutyl-taurin | 98961-89-8

中文名称
——
中文别名
——
英文名称
N-Isobutyl-taurin
英文别名
Isobutyltaurine;2-(2-methylpropylamino)ethanesulfonic acid
N-Isobutyl-taurin化学式
CAS
98961-89-8
化学式
C6H15NO3S
mdl
——
分子量
181.256
InChiKey
MAGRTNDEVAUSLL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.3
  • 重原子数:
    11
  • 可旋转键数:
    5
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    74.8
  • 氢给体数:
    2
  • 氢受体数:
    4

文献信息

  • PD-1/PD-L1 inhibitors
    申请人:Gilead Sciences, Inc.
    公开号:US10710986B2
    公开(公告)日:2020-07-14
    Compounds of Formula (I), methods of using said compounds singly or in combination with additional agents and compositions of said compounds for the treatment of cancer are disclosed.
    本研究公开了式(I)化合物、单独使用所述化合物或将其与其他制剂结合使用的方法以及所述化合物用于治疗癌症的组合物。
  • Glycopeptide Antibiotic Monomer Derivatives
    申请人:Arimoto Hirokazu
    公开号:US20080097078A1
    公开(公告)日:2008-04-24
    Novel glycopeptide antibiotic derivatives. These derivatives are represented by the formula (aglycon part of glycopeptide antibiotic derivative)-(Sac-NH)—R A [wherein (aglycon part of glycopeptide antibiotic derivative) is the part formed by removing the sugar part from a known glycopeptide antibiotic derivative; (Sac-NH) part is an amino sugar part or a sugar chain part containing an amino sugar; and R A represents, e.g., the formula —X 1 —Ar 1 —X 2 —Y—X 3 —Ar 2 (wherein X 1 , X 2 , and X 3 each represents 1) a single bond or 2) a heteroatom or heteroatom-containing group selected from the group consisting of —N═, ═N—, —NR 1 —, —O—, etc.; Y represents —NR 2 CO— or —CONR 2 — (wherein R 2 represents hydrogen or lower alkyl), etc.)]. These derivatives have antibacterial activity against vancomycin-resistant bacteria.
  • PD-1/PD-L1 INHIBITORS
    申请人:Gilead Sciences, Inc.
    公开号:US20190270727A1
    公开(公告)日:2019-09-05
    Compounds of Formula (I), methods of using said compounds singly or in combination with additional agents and compositions of said compounds for the treatment of cancer are disclosed.
  • US5434276A
    申请人:——
    公开号:US5434276A
    公开(公告)日:1995-07-18
  • US7414076B2
    申请人:——
    公开号:US7414076B2
    公开(公告)日:2008-08-19
查看更多